Merge sees positive net income for Q3

TriMed Staff | | Health Imaging | Diagnostic Imaging
Merge Healthcare, a medical imaging solutions provider, has reported its financial results for the third quarter of 2008, which ended Sept. 30.

Net income for the third quarter of 2008 was $400,000, compared to a net loss of $141.6 million in the third quarter of 2007, and a net loss of $18.2 million in the second quarter of 2008, according to the Milwaukee-based Merge.

For the 2008 third quarter, the company said its net sales totaled $14.6 million, compared to $14.1 million in the 2007 third quarter, and $13.3 million in the 2008 second quarter, which ended June 30.

Operating income for the 2008 third quarter was $1.3 million, compared to operating losses of $141.9 million in the 2007 third quarter, and $18.3 million in the 2008 second quarter. Merge said that a goodwill impairment charge of $122.4 million contributed to the operating loss for the 2007 third quarter. The company also noted that a restructuring charge of $7.5 million and a $3 million charge associated with the settlement of a class action lawsuit contributed to the operating loss for the 2008 second quarter.

TriMed Staff

Related Content

First human X-rays in space to take place during upcoming SpaceX mission
Mycoplasma pneumonia: Experts highlight imaging findings linked to the pediatric diagnosis
AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.